Sze‐Fai Yip

987 citations

22 papers · 250 indexed · h-index 9

Impact in

Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Genetics
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in ⓘ

Hematology 14
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 5
Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Chronic Lymphocytic Leukemia Research 4
- Hemoglobinopathies and Related Disorders 2

Co-authors: Yok‐Lam Kwong (6 shared papers)Harold K. K. Lee (5 shared papers)Edmond S.K. (4 shared papers)C.C So (4 shared papers)Li-Chong Chan (4 shared papers)June S. M. Lau (5 shared papers)K.C. Ngan (1 shared paper)Thomas S. K. Wan (5 shared papers)
Journals: Cancer (3 papers)Oncology Reports (2 papers)Annals of Hematology (2 papers)British Journal of Haematology (1 paper)Leukemia Research (1 paper)
Partner nations: China Hong Kong Australia

In The Last Decade

Sze‐Fai Yip

21 papers receiving 246 citations

Peers

Countries citing papers authored by Sze‐Fai Yip

Since Specialization

Citations

This map shows the geographic impact of Sze‐Fai Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sze‐Fai Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sze‐Fai Yip more than expected).

Fields of papers citing papers by Sze‐Fai Yip

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sze‐Fai Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sze‐Fai Yip. The network helps show where Sze‐Fai Yip may publish in the future.

Co-authors

The 25 scholars most cited alongside Sze‐Fai Yip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sze‐Fai Yip Line = papers co-authored together Sze‐Fai Yip links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study Cancer ·Harinder Gill, Rita Yim, Harold K. K. Lee, Vivien Mak, Shek‐Ying Lin, Bonnie Kho, Sze‐Fai Yip, June S. M. Lau, Wah Li, Ho‐Wan Ip, Yu‐Yan Hwang, Thomas S. Y. Chan, Eric Tse, Wing‐Yan Au, Cyrus R. Kumana, Yok‐Lam Kwong	2018	44
2	A novel zebrafish jak2aV581F model shared features of human JAK2V617F polycythemia vera Experimental Hematology ·Alvin C.H., August Fan, Alister C. Ward, Clifford Liongue, Rowena S. Lewis, Shuk Han Cheng, P.K. Chan, Sze‐Fai Yip, Raymond Liang, Anskar Y.H. Leung	2009	32
3	Association of HLA‐B22 serotype with SARS‐CoV‐2 susceptibility in Hong Kong Chinese patients HLA ·Yuk‐Lin Yung, Chi‐Keung Cheng, Chan Hong-Mo, Jenny Xia, Kin‐Mang Lau, Raymond Wong, Alan Wu, Raymond Chu, Alice C. C. Wong, Eudora Y. D. Chow, Sze‐Fai Yip, Jennifer Nga‐Sze Leung, Cheuk‐Kwong Lee, Margaret H.L. Ng	2020	29
4	Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3 Cancer ·Chunxiao Zhang, Stephen S.Y. Lam, Garret M. K. Leung, Sze‐Pui Tsui, Ning Yang, Nelson K.L. Ng, Ho‐Wan Ip, Chun Hang Au, Tsun‐Leung Chan, Edmond S.K., Sze‐Fai Yip, Harold K. K. Lee, June S. M. Lau, Tsan‐Hei Luk, Wa Li, Yok‐Lam Kwong, Anskar Y.H. Leung	2019	22
5	Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study Cancer ·Harinder Gill, Cyrus R. Kumana, Rita Yim, Yu‐Yan Hwang, Thomas S. Y. Chan, Sze‐Fai Yip, Harold K. K. Lee, Vivien Mak, June S. M. Lau, Chi‐Chung Chan, Bonnie Kho, Raymond Wong, Wa Li, Shek‐Yin Lin, Chi‐Kuen Lau, Ho‐Wan Ip, Rock Y. Y. Leung, Clarence Lam, Yok‐Lam Kwong	2019	19
6	Chondroblastoma of the lumbar spine with cauda equina syndrome Spinal Cord ·O M Chung, Sze‐Fai Yip, K.C. Ngan, W F Ng	2003	18
7	Diagnostic utility of dual fusion PML/RARα translocation DNA probe (D-FISH) in acute promyelocytic leukemia Oncology Reports ·Thomas S. K. Wan, C.C So, Koon-Chun Hui, Sze‐Fai Yip, Edmond S.K., Li-Chong Chan	2007	16
8	Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia Annals of Hematology ·Eric Tse, Anskar Y.H. Leung, Joycelyn Sim, Harold K. K. Lee, Herman S.Y. Liu, Sze‐Fai Yip, Yok‐Lam Kwong	2011	13
9	A case of Streptococcus mitis endocarditis successfully treated by linezolid. PubMed ·K H L Ng, S Lee, Sze‐Fai Yip, Tak‐Lun Que	2005	11
10	Genetic predisposition of white matter infarction with protein S deficiency and R355C mutation Neurology ·Thomas Leung, Sze‐Fai Yip, Christina Lam, Tsun‐Leung Chan, Wynnie W.M. Lam, Deyond Y.W. Siu, Yu Fan, Natalie Pui Ha Chan, H.S.Y. Liu, Lee-Lee Chan, Ka Sing Wong	2010	7
11	A complex MLL rearrangement identified five years after initial MDS diagnosis results in out-of-frame fusions without progression to acute leukemia Cancer Genetics ·Claus Meyer, Eric Kowarz, Sze‐Fai Yip, Thomas S. K. Wan, Tai‐Kwong Chan, Theo Dingermann, Li-Chong Chan, Rolf Marschalek	2011	6
12	Thalassemia Intermedia Due to Co‐inheritance of β⁰/β⁺‐Thalassemia and (– –^SEA)α‐Thalassemia/Hb Westmead [α122(H5)His > Gln (α2)] in a Chinese Family Hemoglobin ·Wai‐Shan Wong, Amy Y‐Y. Chan, Sze‐Fai Yip, Edmond S.K.	2004	6
13	SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response International Journal of Molecular Sciences ·Herbert Augustus Pitts, Chi‐Keung Cheng, Joyce S. Cheung, Murphy Ka-Hei Sun, Yuk‐Lin Yung, Hoi–Yun Chan, Raymond Wong, Sze‐Fai Yip, Ka Ngai Lau, Wai Shan Wong, Radha Raghupathy, Natalie P. H. Chan, Margaret H.L. Ng	2023	5
14	A dual colour dual fusion fluorescence in situ hybridisation study on the genesis of complex variant translocations in chronic myelogenous leukaemia Oncology Reports ·C.C So, Thomas S. K. Wan, Sze‐Fai Yip, Li-Chong Chan	2008	5
15	Absence of microsatellite instability in primary myelodysplastic syndrome. International Journal of Molecular Medicine ·K. Sri Manjari, CT Kong, T.S.K. Wan, W.Y. Au, Joyce Chan, Sze‐Fai Yip, L.C. Chan	2000	4
16	Functional alterations of Lin−CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia Leukemia Research ·Qian Sun, C.C So, Sze‐Fai Yip, Thomas S. K. Wan, Shiu‐Kwan Ma, L.C. Chan	2008	3
17	Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis Hematology ·Harinder Gill, Anskar Y.H. Leung, Chi‐Chung Chan, June S. M. Lau, Candia Hay Nun Chan, Sze‐Fai Yip, Herman Liu, Bonnie Kho, Vivien Mak, Harold K. K. Lee, Shek‐Ying Lin, Chi‐Kuen Lau, Yok‐Lam Kwong	2015	3
18	RUNX3 Expression Is an Independent Prognostic Factor in Cytogenetically Abnormal Adult Acute Myeloid Leukemia (AML) Patients with Wild-Type FLT3. Blood ·Tsz-ki Kwan, Chi‐Keung Cheng, Suk‐Hang Cheng, Natalie P. H. Chan, Rosalina K. L. Ip, Raymond Wong, Sze‐Fai Yip, Chi Kong Li, Margaret H.L. Ng	2010	3
19	BCR-ABL mutational studies for predicting the response of patients with chronic myeloid leukaemia to second-generation tyrosine kinase inhibitors after imatinib failure. PubMed ·Tsz-ki Kwan, Edmond S.K., Yuk Wah Chan, Thomas S. K. Wan, Herman S Y Liu, Joycelyn Sim, Yiu Ming Yeung, A K W Lie, Sze‐Fai Yip	2009	2
20	Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy Annals of Hematology ·Yu‐Yan Hwang, Thomas Sau Yan Chan, Florence Hoi Yan Chan, Chris W. P. Lau, Yan-Yan Luk, Grace W. N. Lau, Ka-Po Chan, Kwan-Hung Leung, Bonnie Kho, June S. M. Lau, Chi‐Kuen Lau, Vivien Mak, Sze‐Fai Yip, Shek‐Ying Lin, Joycelyn Sim, Yok‐Lam Kwong	2022	1

About Sze‐Fai Yip

Sze‐Fai Yip is a scholar working on Hematology, Genetics, Molecular Biology, Rheumatology and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 250 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Retinoids in leukemia and cellular processes (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Kruppel-like factors research (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). The work is most often cited by research in Hematology (120 citations), Genetics (39 citations), Biochemistry (21 citations), Infectious Diseases (38 citations) and Molecular Biology (117 citations). Sze‐Fai Yip has collaborated with scholars based in China, Hong Kong and Australia. Frequent co-authors include Yok‐Lam Kwong, Harold K. K. Lee, Edmond S.K., C.C So, Li-Chong Chan, June S. M. Lau, K.C. Ngan, Thomas S. K. Wan, Eric Tse and Vivien Mak. Their work appears in journals such as Cancer, Oncology Reports, Annals of Hematology, British Journal of Haematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact